Literature DB >> 1080632

Morphology of chronic lymphocytic leukemia and its relationship to survival.

L C Peterson, C D Bloomfield, R D Sundberg, K J Gajl-Peczalska, R D Brunning.   

Abstract

The morphology of lymphocytes in blood and bone marrow from patients with chronic lymphocytic leukemia was studied; blood lymphocyte morphology was related to survival. Three primary morphologic groups emerged. Group 1 was characterized by small to medium-sized lymphocytes with narrow rims of cytoplasm and coarsely clumped nuclear chromatin. In group II the predominant lymphocytes were large with abundant cytoplasm. Group III was characterized by a heterogeneous population of lymphocytes with characteristics of both groups I and II. Clinical features of the patients were studied, and B and T typing of the lymphocytes was done. The median survival in group I was 26+ months; in group II 46+ months; and in group III 50+ months. Our data are at variance with previous reports and suggest that survival in patients with large lymphocytes is longer than in those with small lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080632     DOI: 10.1016/0002-9343(75)90389-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Prolymphocytic leukemia.

Authors:  D Huhn; E Thiel; H Rodt; H Theml
Journal:  Klin Wochenschr       Date:  1978-07-15

2.  Morphology of lymphatic cells and of their derived tumours.

Authors:  F Rilke; S Pilotti; A Carbone; L Lombardi
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

3.  A hemalog D analysis of chronic lymphocytic leukaemia and other lymphoproliferative disorders affecting the blood.

Authors:  K G Patterson; A H Goldstone; J D Richards; J C Cawley
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

4.  T lymphocytes bearing complement receptors in a patient with chronic lymphocytic leukaemia.

Authors:  H R Toben; R G Smith
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

5.  The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.

Authors:  David Oscier; Monica Else; Estella Matutes; Ricardo Morilla; Jonathan C Strefford; Daniel Catovsky
Journal:  Br J Haematol       Date:  2016-05-06       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.